Simpler Grants.gov #RFA-AI-27-003

NIH Solicits Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC) Services

The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to establish an Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC): - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - No specific Original Equipment Manufacturers (OEMs) or commercial vendors are named in this opportunity - Services Requested: - Clinical study development and support for autoimmune diseases, mucosal immunology, and primary immune deficiencies - Regulatory support for both domestic and international studies - Site monitoring and repository management - Manuscript production and study archiving - Biostatistical support for clinical trials - Collaboration with the DAIT Clinical Data and Safety Management Center (CDSMC) - Potential emergent support for other NIAID networks and clinical trials - Notable Requirements: - The center will serve as a central resource for multiple clinical research networks - The award will be a cooperative agreement with an anticipated single recipient - Estimated program funding is $8,000,000 - No products, part numbers, or OEM-specific requirements are specified - Opportunity is focused on health research and clinical trial coordination

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to establish an Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC) to provide clinical study development, regulatory support, site monitoring, repository management, manuscript production, study archiving, and biostatistical support for clinical trials in autoimmune diseases, mucosal immunology, and primary immune deficiencies. The center will collaborate with the DAIT Clinical Data and Safety Management Center and may support other networks and clinical trials within NIAID's mission. The funding instrument is a cooperative agreement with an estimated program funding of $8,000,000 and one expected award. The opportunity is discretionary and categorized under health funding activities.

View original listing